Report of Foreign Issuer (6-k)
December 27 2017 - 8:38AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of December 2017
Commission File Number 001-37381
MEDIGUS
LTD.
(Translation of registrant’s name into English)
Omer
Industrial Park, No. 7A, P.O. Box 3030, Omer 8496500, Israel
(Address of principal
executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.
Form
20-F ☒
Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __
EXPLANATORY NOTE
On
December 27, 2017, Medigus Ltd. issued a press release titled: “Medigus Announces First MUSE™ Procedure for the Treatment
of GERD Performed in Israel at Shaare-Zedek Medical Center.” A copy of this press release is furnished herewith as exhibit
99.1.
This
Form 6-K is incorporated by reference into the Company’s Registration Statements on Form F-3 (File No. 333-213280) and Form
S-8 (File No. 333-206803 and No. 333-221019).
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
|
MEDIGUS LTD.
|
|
|
|
|
|
Date: December 27, 2017
|
By:
|
/s/ Oded Yatzkan
|
|
|
|
Oded Yatzkan
|
|
|
|
Chief Financial Officer
|
EXHIBIT INDEX
-3-
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Apr 2023 to Apr 2024
